How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market

How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
DeviceTalks Podcast Network
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market

Jun 24 2022 | 01:13:29

/
Episode June 24, 2022 01:13:29

Hosted By

Kayleen Brown Tom Salemi

Show Notes

In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific. Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer. This episode is sponsored by AcuityMD. Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.

Other Episodes